Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are a unique class of antihyperglycemic agents that enhance the actions of the naturally occurring gut peptide GLP-1. With a low risk of hypoglycemia and favorable cardioprotective effects and safety in at-risk patients with diabetes, there has been a shift in practice guidelines for earlier use in treatment.
Interactive clinical review and case study
After completing this activity, participants should be better able to:
- Apply current guidelines and evidence supporting early initiation of GLP-1 RAs in appropriate patients with type 2 diabetes
- Outline the role of GLP-1 RA therapy in patients requiring improved glycemic control, weight reduction, and/or cardiovascular risk reduction
- Implement strategies that incorporate shared decision-making with patients to foster adherence and improve patient outcomes
NPs and PAs
Joint Accreditation Statement
In support of improving patient care, Continuing Education Alliance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
Nursing contact hours: 1.00, which includes 1.00 hours of pharmacology credit
AAPA Credit Designation
Continuing Education Alliance has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credits. Approval is valid until November 11, 2020. PAs should only claim credit commensurate with the extent of their participation.
PA Planner: Lawrence Herman, MPA, PA-C, University of South Carolina School of Medicine
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity was developed from a series of programs cosupported by educational grants from Astellas Pharma, Inc.; Biogen; Genentech; Gilead Sciences, Inc.; Novartis Pharmaceuticals Corporation; and Novo Nordisk, Inc.
This activity is supported by an educational grant from Novo Nordisk, Inc.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Continuing Education Alliance, Practicing Clinicians Exchange, or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Continuing Education Alliance are required to disclose to the audience any relevant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Thompson has no relevant financial relationships to disclose.
Mr Herman: consultant/speaker: Novo Nordisk.
None of the members of the Planning Committee or CE Alliance staff have any relevant relationships to disclose, except Mr Herman as noted above.
Participants wishing to earn CE/CME credit must:
- Read the content
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form online
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hour.
Release date: November 12, 2019
Expiration date: November 11, 2020
Any internet connected computer or mobile device with any of the following browsers: Internet Explorer, Google Chrome, Mozilla Firefox, Safari.
© 2019 Practicing Clinicians Exchange. All Rights Reserved. CPCE95219-7E